CORDIS · 101007799 · H2020

Inno4Vac Innovations to accelerate vaccine development and manufacture

Coordinator: EUROPEAN VACCINE INITIATIVE EV (DE)

Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling persistent scientific bottlenecks in vaccine development and for de-risking and accelerating this process. To reach this aim the project is divided into four interlinked subtopics. In Subtopic 1, artificial intelligence in combination with big data analysis and computational modelling will be used to build an open-access and cloud-based platform for in silico vaccine efficacy assessment and development. Subtopic 2 will develop new and improved controlled …

EU contribution
€18.6M
Total cost
€39.3M
Period
2021-09-01 → 2027-02-28
Framework
Horizon 2020 (2014–2020)
Funding scheme
RIA
Call
H2020-JTI-IMI2-2020-20-two-stage
Status
SIGNED

About Horizon 2020 (2014–2020)

Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.

Co-funding: the European Union contributes €18.6M toward a total project budget of €39.3M — a funding rate of 47%, with the remainder covered by the consortium partners. The project runs over approximately 5.5 years from 2021-09-01 to 2027-02-28.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the RIA funding scheme.
What is the EU contribution?
The European Commission contributes €18.6M toward a total project budget of €39.3M.
Which EU programme funds it?
The project is funded under Horizon 2020 (2014–2020), call H2020-JTI-IMI2-2020-20-two-stage.
Who coordinates the project?
The project is coordinated by EUROPEAN VACCINE INITIATIVE EV (DE).
What is the project timeline?
The project runs from 2021-09-01 to 2027-02-28 — approximately 5.5 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101007799.